- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Aurobindo Pharma shares fall after USFDA warning letter
New Delhi: Shares of Aurobindo Pharma on Friday dipped over 3 per cent after the company said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API (Active Pharmaceutical Ingredient) manufacturing facility. The stock tumbled 3.17 per cent to settle at Rs 695.15 on BSE. During the day, it tanked 4.65 per cent to Rs 684.50. On NSE, it dipped 3.12...
New Delhi: Shares of Aurobindo Pharma on Friday dipped over 3 per cent after the company said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API (Active Pharmaceutical Ingredient) manufacturing facility.
The stock tumbled 3.17 per cent to settle at Rs 695.15 on BSE. During the day, it tanked 4.65 per cent to Rs 684.50. On NSE, it dipped 3.12 per cent to close at Rs 695.15.In volume terms, 3.50 lakh shares were traded on BSE and over 58.79 lakh on NSE.
Doctor of Pharmacy
Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.